We added the following clinical trials to Metastatic Trial Search for May 2026. To see all clinical trials, please visit Metastatic Trial Search.

ER/PR Positive Trials

• Inavolisib With Fulvestrant for Advanced HR+, HER2- Breast Cancer with PIK3CA Mutations

HER2 Positive Trials

• CGT4255 for Advanced HER2+ Breast Cancer with or without ERBB2 Mutations
• Educational Program to Improve Side Effects for People With HER2+ or HER2 Low Breast Cancer Receiving Targeted Therapy
• Pidnarulex and Trastuzumab Deruxtecan for HER2 Positive Advanced Breast Cancer

HER2 Negative Trials

• BNT326 Alone or with Immunotherapy for Advanced HER2- Breast Cancer

Triple Negative Trials

• PET/MRI Scans to Predict Response to Immunotherapy in Triple Negative Breast Cancer

Other Trials

• IDOV-Immune for Advanced Breast Cancer
• Exploring How Social Factors Affect Inflammation
• SYS6043 Antibody Drug Conjugate for Advanced Breast Cancer

Last Modified on May 8, 2026